|
Stability Concerns Prompt Recall of Genzyme’s Kidney Transplant Drug
Genzyme is voluntarily recalling nine lots of its kidney transplant drug Thymoglobulin after one product lot failed a periodic stability test, the Sanofi subsidiary says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives